The official blog of the Lung Institute.

Related Conditions to Interstitial Lung Disease

Related Conditions to ILD Lung Institute

Breathing comes naturally to many of us. In doing so, we breathe in much needed oxygen into our bloodstream, which enables the body to work and grow. Almost every day, an average person will breathe in and out nearly 25,000 times. Now imagine having a lung disease and struggling just to do this very simple action.

One such lung disease is  interstitial lung disease (ILD). Interstitial lung disease is an umbrella term used to classify a family of about 100 diverse types of pulmonary conditions that impede the normal absorption of oxygen in the lungs. All of these conditions have an effect on the interstitium, which is the tissue and space around the alveoli—the cluster-like air sacs—in the lungs.

The interstitium is usually relatively invisible, but when an individual has interstitial lung disease, the interstitium becomes progressively scarred and more visible. This scarring is characteristic of the entire family of diseases encompassed by interstitial lung disease. The scar tissue affects the ability for oxygen to pass from the lungs into the bloodstream.

Interstitial lung disease can be a very complex puzzle. With over 100 different forms of the disease, knowing how to treat the condition comes down to an individual basis. All of the pieces eventually fall right into place, showing the bigger picture. One piece of this puzzle is especially holding the interest of some researchers: what related conditions can impact interstitial lung disease?

What Else Can Occur?

As with any medical condition, these is a pretty good chance that other complications might be in play. In the instance of ILD, other disorders or illnesses can develop over a period of time, adding additional stress to an already chronic disease. According to the Mayo Clinic, here are some related conditions to interstitial lung disease:

  • Pulmonary Hypertension – This condition affects only the arteries within the lungs. While scarring is present, blood flow is limited, thus causing increased pressure.
  • Cor Pulmonale – Also known as right-sided heart failure; this disorder can happen when the right side of the heart has to pump blood harder and faster through blocked arteries.
  • Respiratory Failure – In the final stage of ILD, respiratory failure can occur when low-oxygen levels are present and there is increased pressure in the pulmonary arteries.

Stop Managing the Condition and Start Treating It

Stem cell therapy for lung disease has been a growing treatment option over the past few years. At the Lung Institute, a progressive stem cell treatment clinic that has emerged as a leader in the global stem cell community, they use stem cells from the patient’s own body to treat lung disease. The cells are called autologous stem cells. These cells are taken from the patient’s blood (venous stem cells) or bone marrow. The stem cells are then cultured and multiplied and returned to the body through an intravenous drip. The new healthy cells are attracted to the areas of the damaged lung cells and get to work promoting the healing of lung tissue. This results in the ability of the patients to breathe easier and inevitably get their life back.

If you or a loved one has emphysema, stem cell treatment may be right for you. Contact the Lung Institute for a free consultation or call (800) 729-3065.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.